Changing the world.
One world at a time.

Ceregate is transforming the treatment of neurological disorders with its innovative, minimally invasive Computer-Brain Interface (CBI) technology. Our software works with proven neuromodulation implants (like DBS and SCS) to directly communicate with the nervous system, addressing issues like movement and balance disorders.

With over 85 successful patient trials and partnerships with leading medical device companies, Ceregate provides personalized solutions to meet critical medical needs, such as improving mobility in Parkinson's patients and restoring balance in those with vestibular disorders. Our mission is to help millions live more independently.

Technology made for humanity.

At Ceregate, we don’t just rely on theory—our technology has proven effective with over 85 patients , demonstrating its reliability across multiple neural circuits. Our solutions address critical unmet needs like Freezing of Gait in Parkinson’s patients and balance disorders, providing life-changing improvements.

Ceregate is recognized for its innovation, with ongoing FDA trials and the pursuit of Breakthrough Device status. Trusted by major industry leaders, our patented, hardware-agnostic platform is flexible and scalable, adaptable across various medical conditions.

Clinically validated.
Ethically driven.

Clinically validated and ethically driven, our technology is designed to integrate into existing healthcare infrastructures, ensuring quicker access for patients and faster adoption by the medical community.

Our focus is on creating minimally invasive, flexible CBI platforms that build on existing neuromodulation implants to transmit information directly to the nervous system.

All advantages

Our innovative CBI platform is designed to repurpose neuromodulation implants, such as Deep Brain Stimulation (DBS) and Spinal Cord Stimulation (SCS) devices, to communicate with the nervous system. This approach offers several key benefits:

1. Minimally invasive

By leveraging already-approved implants, we reduce the need for additional surgeries, lowering risks for patients and speeding up adoption.




2. Hardware-agnostic
and modular

With its hardware-agnostic design, our platform is flexible enough to be applied across a wide array of medical conditions, from mobility impairments to sensory restoration. This scalability makes Ceregate’s technology not only versatile but also future-proof.




3. Proven in humans

We’ve successfully tested our CBI platform in over 85 participants, demonstrating effective information transmission through multiple neural pathways.




4. High-performance

Our platform significantly enhances the CBI transmission bitrate, enabling both simple applications and more advanced solutions like artificial hearing and vision.




5. Partnership-driven

The versatility of our platform allows us to collaborate with neuromodulation device manufacturers, ensuring tailored solutions for each specific medical condition.